awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35285011-10CD6455-0741-4561-9CA5-45F46F98D043
Q35285011-10CD6455-0741-4561-9CA5-45F46F98D043
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35285011-10CD6455-0741-4561-9CA5-45F46F98D043
VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study.
P2860
Q35285011-10CD6455-0741-4561-9CA5-45F46F98D043
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35285011-10CD6455-0741-4561-9CA5-45F46F98D043
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ce860f9b629b2632ab831d84c0ac8ed697cb672
P2860
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.